AIDS and Behavior

, Volume 22, Issue 6, pp 2018–2025 | Cite as

Tobacco Use and Sustained Viral Suppression in Youth Living with HIV

  • Kristi E. Gamarel
  • Andrew O. Westfall
  • Michelle A. Lally
  • Sybil Hosek
  • Craig M. Wilson
  • The Adolescent Medicine Trials Network for HIV/AIDS Intervention
Original Paper


Tobacco has been associated with worse HIV disease progression in adult samples of people living with HIV; however, studies have yet to examine these effects in youth living with HIV (YLWH). This study examined the association between tobacco smoking behaviors and sustained viral suppression among a sample of 820 YLWH who were recruited through the Adolescent Medicine Trials Network for HIV Interventions. Participants completed a cross-sectional survey and then staff abstracted viral suppression data from medical records for up to 26 weeks prior to enrollment. Overall, 20.4% of youth reported daily or almost daily tobacco use. In multivariable analyses, older age and daily or almost daily tobacco smoking, and ART adherence remained statistically significant in predicting sustained viral suppression over the study period. These findings underscore the need for tobacco screening and interventions in HIV care settings in order to identify youth in need of additional smoking cessation services.


Tobacco use HIV disease progression Youth 


El tabaco se ha asociado con una progresión peor de la enfermedad del VIH en muestras adultas de personas que viven con el VIH; sin embargo, los estudios todavía tienen que examinar estos efectos en los jóvenes que viven con el VIH (YLWH). Este estudio examinó la asociación entre los hábitos de fumar tabaco y la supresión viral sostenida entre una muestra de 820 YLWH que fueron reclutados a través de la Red de Investigación de Medicina del Adolescente para Intervenciones de VIH. Los participantes completaron una encuesta transversal y luego el personal extrajo los datos de supresión viral de los registros médicos hasta 26 semanas antes de la inscripción. En general, el 20,4% de los jóvenes informó un consumo diario o casi diario de tabaco. En los análisis multivariables, la edad avanzada y el tabaquismo diario o casi diario, y la adherencia a la terapia antirretroviral permanecieron estadísticamente significativas en la predicción de la supresión viral sostenida durante el período del estudio. Estos hallazgos subrayan la necesidad de evaluación del uso de tabaco e intervenciones en entornos de atención del VIH con el fin de identificar a los jóvenes que necesitan servicios adicionales para dejar de fumar.



Clinics were located in the following locations: Los Angeles, California; Washington, DC; Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois; Philadelphia, Pennsylvania; New York City, New York; New Orleans, Louisiana; Memphis, Tennessee; Miami, Florida; Tampa, Florida; Detroit, Michigan; Denver, Colorado; and Houston, Texas. This research was supported by The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from the National Institutes of Health [U01HD040533 and U01HD040474] through the National Institute of Child Health and Human Development (Kapogiannis, Lee), with supplemental funding from the National Institutes on Drug Abuse (Davenny, Kahana) and Mental Health (Brouwers, Allison). Support was also provided to the first author by the Providence/Boston Center for AIDS Research (P30AI042853, PI: Cu-Uvin). The study was scientifically reviewed by the ATN’s Behavioral Leadership Group. Network, scientific and logistical support was provided by the ATN Coordinating Center (Wilson, Partlow) at the University of Alabama at Birmingham. Network operations and data management support was provided by the ATN Data and Operations center at Westat, Inc. (Korelitz, Driver). We acknowledge the contribution of the investigators and staff at the following sites that participated in this study: University of South Florida, Tampa (Emmanuel, Lujan-Zilbermann, Julian), Children’s Hospital of Los Angeles (Belzer, Flores, Tucker), Children’s National Medical Center (D’Angelo, Hagler, Trexler), Children’s Hospital of Philadelphia (Douglas, Tanney, DiBenedetto), John H. Stroger Jr. Hospital of Cook County and the Ruth M. Rothstein CORE Center (Martinez, Bojan, Jackson), Montefiore Medical Center (Futterman, Enriquez-Bruce, Campos), Tulane University Health Sciences Center (Abdalian, Kozina, Baker), University of Miami School of Medicine (Friedman, Maturo, Major-Wilson), St. Jude’s Children’s Research Hospital (Flynn, Dillard), Baylor College of Medicine (Paul, Calles, Cooper), Wayne State University (Secord, Cromer, Green-Jones), Johns Hopkins University School of Medicine (Agwu, Anderson, Park), The Fenway Institute—Boston (Mayer, George, Dormitzer), and University of Colorado, Denver (Reirden, Hahn, Witte). We are greatly appreciative to all of the adolescents and young adults who participated in this study. Funding was provided by National Institute on Alcohol Abuse and Alcoholism (Grant No. U24AA022000).

Compliance with Ethical Standards

Conflict of interest

Each of the authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    McKinney RE Jr, Rodman J, Hu C, et al. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics. 2007;120:e416–23.CrossRefPubMedGoogle Scholar
  2. 2.
    Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDs. 2014;28:128–35.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Rumptz MH, Tobias C, Rajabiun S, et al. Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDs. 2007;21:S30–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Gagliardo C, Murray M, Saiman L, Neu N. Initiation of antiretroviral therapy in youth with HIV: a U.S.-based provider survey. AIDS Patient Care STDs. 2013;27:498–502.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gamarel KE, Brown L, Kahler CW, et al. Prevalence and correlates of substance use among youth living with HIV in clinical settings. Drug Alcohol Depend. 2016;169(1):11–8.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Rubinstein ML, Harris DR, Rudy BJ, Kapogiannis BG, Aldrovandi, GM, Mulligan K. Exploration of the effect of tobacco smoking on metabolic measures in young people living with HIV. AIDS Res Treat. 2014:1–8.Google Scholar
  8. 8.
    Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health. 2006;96:1060–5.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nieman RB, Fleming J, Coker RJ, et al. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS. 1993;7:705–10.CrossRefPubMedGoogle Scholar
  10. 10.
    Akgun KM, Gordon K, Pisani M, et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr. 2013;62:52–9.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Calvo-Sanchez M, Perello R, Perez I, et al. Differences between HIVinfected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Med. 2013;14:40–8.CrossRefPubMedGoogle Scholar
  12. 12.
    De P, Farley A, Lindson N, et al. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013:11–15.Google Scholar
  13. 13.
    Metersky ML, Colt HG, Olson LK, et al. AIDS-related spontaneous pneumothorax. Risk factors and treatment. Chest. 1995;108:946–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Saves M, Chene G, Ducimetiere P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37:292–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Winstone TA, Man SF, Hull M, et al. Epidemic of lung cancer in patients with HIV infection. Chest. 2013;143:305–14.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health. 2010;100:1896–903.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Davies TL, Gompels M, Johnston S, et al. Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals-a clinical cohort study. BMJ Open. 2013;3:e003245.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hile SJ, Feldman MB, Alexy ER, Irvine MK. Recent tobacco smoking is associated with poor HIV medical outcomes among HIV-infected individuals in New York. AIDS Behav. 2016;20(8):1722–9.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gamarel KE, Neilands TB, Conroy AA, Dilworth SE, Lisha N, Taylor JM, Darbes LA, Johnsno MO. A longitudinal study of persistent smoking among HIV-positive gay and bisexual men in primary relationships. Addict Behav. 2017;66:118–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Cioe PA, Gamarel KE, Pantalone DW, Monti PM, Mayer KH, Kahler CW. Cigarette smoking and antiretroviral therapy (ART) adherence in a sample of heavy drinking HIV-infected men who have sex with men (MSM). AIDS Behav. 2017;21(7):1956–63.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Cioe PA. Smoking cessation interventions in HIV-infected adults in North America: a literature review. J Addict Behav Ther Rehabil. 2013;2(3):1000112.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    WHO Assist Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRefGoogle Scholar
  23. 23.
    Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions. Referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1–3):280–95.CrossRefPubMedGoogle Scholar
  24. 24.
    Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156:607–61.CrossRefPubMedGoogle Scholar
  25. 25.
    Derogatis LR. BSI brief symptom inventory: administration, scoring, and procedures manual. Bloomington, MN: PsychCorp; 1993.Google Scholar
  26. 26.
    Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML. Effects of cigarette smoke on the immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP-sensitive calcium stores. J Pharmacol Exp Ther. 2000;293:166–71.PubMedGoogle Scholar
  27. 27.
    Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Espinosa EM, Sorensen JR, Lopez MA. Youth pathways to placement: the influence of gender, mental health needs and trauma on confinement in juveline justice system. J Youth Adolesc. 2013;42(12):1824–36.CrossRefPubMedGoogle Scholar
  29. 29.
    Houston TK, Scarinci IC, Person SD, Greene PG. Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health. 2005;95(6):1056–61.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Current cigarette smojng among HIV-positve current and former drug users: associations with individual and social characteristics. AIDS Behav. 2014;18(7):1368–77.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Kristi E. Gamarel
    • 1
    • 2
  • Andrew O. Westfall
    • 3
  • Michelle A. Lally
    • 4
    • 5
  • Sybil Hosek
    • 6
  • Craig M. Wilson
    • 7
  • The Adolescent Medicine Trials Network for HIV/AIDS Intervention
  1. 1.Department of Health Behavior and Health EducationUniversity of Michigan School of Public HealthAnn ArborUSA
  2. 2.Center for Sexuality and Health DisparitiesUniversity of MichiganAnn ArborUSA
  3. 3.Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  4. 4.Lifespan Hospital SystemProvidenceUSA
  5. 5.Alpert Medical SchoolBrown UniversityProvidenceUSA
  6. 6.John Stroger Hospital of Cook CountyChicagoUSA
  7. 7.Department of EpidemiologyUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations